La Franca, Lamberto
Rutigliani, Carola
Checchin, Lisa
Lattanzio, Rosangela
Bandello, Francesco
Cicinelli, Maria Vittoria http://orcid.org/0000-0003-2938-0409
Article History
Received: 27 November 2023
Accepted: 7 March 2024
First Online: 8 April 2024
Declarations
:
: Lamberto La Franca, Carola Rutigliani and Lisa Checchin have nothing to disclose. Francesco Bandello consultant for: Allergan Inc (Irvine, California, USA), Bayer Shering-Pharma (Berlin, Germany), Hoffmann-La-Roche (Basel, Switzerland), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, USA), Boehringer-Ingelheim, Fidia Sooft, Ntc Pharma, Sifi. Rosangela Lattanzio consultant for: AbbVie (North Chicago, Illinois, USA), Bayer Shering-Pharma (Berlin, Germany), Novartis (Basel, Switzerland), Sifi. Maria Vittoria Cicinelli and Francesco Bandello are Editorial Board members of <i>Ophthalmology and Therapy</i>. Maria Vittoria Cicinelli and Francesco Bandello were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: All investigations were conducted following the principles outlined in the Declaration of Helsinki for research involving human subjects. The study received approval from the San Raffaele Hospital Ethics Committee under the protocol name “OCTA-MIMS” (97/INT/2021), and written informed consent was obtained from all subjects.